Groningen, Netherlands

Elisabeth De Vries

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elisabeth De Vries: Innovator in Therapeutic Methods

Introduction

Elisabeth De Vries is a prominent inventor based in Groningen, Netherlands. She has made significant contributions to the field of medical treatments, particularly in the area of disorders related to c-Met signaling pathways. Her innovative approach has led to the development of a unique method for treating, ameliorating, or preventing various disorders.

Latest Patents

Elisabeth holds 1 patent for her work titled "Methods and compositions for treating disorders." This patent describes a method that involves blocking the signaling pathway of c-Met. The method includes administering a therapeutically effective amount of a composition that contains a lipocalin mutein or a fragment or variant thereof. Additionally, her patent encompasses a diagnostic composition suitable for use in immuno-imaging techniques to detect the presence of c-Met.

Career Highlights

Elisabeth is currently associated with Pieris Pharmaceuticals GmbH, where she continues to advance her research and innovations. Her work is pivotal in developing new therapeutic strategies that can significantly impact patient care.

Collaborations

Elisabeth collaborates with notable colleagues, including Shane Olwill and Hendrik Gille. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Elisabeth De Vries is a trailblazer in the field of therapeutic innovations, with her patent reflecting her commitment to improving treatment methods for various disorders. Her contributions are invaluable to the medical community and continue to inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…